Cancer Care in the Time of COVID19
Cancer doesn’t stop because of COVID19, and many of the challenges (logistical, psychological, and physical) intensify. The goal of this program is to give insight to help guide healthcare providers in the field of oncology on what to do in this time and to help answer the question, “How can we best care for cancer patients in an uncertain and dangerous healthcare environment?”
Mary Catherine Altmiller, BSN | Lehigh Valley Health Network
Laura Freedman, MD | University of Miami
Christina Gomez, MD | Yale University
Ranju Gupta, MD | Lehigh Valley Health Network
Shayma Kazmi, MD | Cancer Treatment Centers of America
Jennifer Klemp, PhD | University of Kansas
Sharyn Lewin, MD | Holy Name Medical Center
Arturo Loaiza Bonilla, MD | Cancer Treatment Centers of America
Reshma Mahtani, DO | University of Miami
Sharla Manglitz, MD | Patient at the University of Miami
Jane Meisel, MD | Emory University
Kristina Mirabeau-Beale, MD | 21st Century Oncology
Lauren Nye, MD | University of Kansas
Ena Segota, MD | Holy Cross Hospital
Helosia Soares, MD | University of Utah
To discuss the greatest concerns in standard care delivery outside of things like PPE
To understand how to manage work-life balance when there are new considerations like working form home and children home schooling
To analyze the impact on cancer care from COVID19
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferencing. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this enduring activity for a maximum of 4.50 AMA PRA Category 1 CreditsTM for physicians and 4.50 contact hours for nurses. Learners should claim only the credit commensurate with the extent of their participation in the activity.
How This Course Works
This course is eight pre-recorded sessions titled Cancer Care in the Time of COVID19. Medical experts discuss how they are changing the way they practice during these uncertain times and share their opinions and best practices.
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
A link to the evaluation will be provided at the conclusion of the course.
If you have questions regarding this enduring material activity, please contact us at firstname.lastname@example.org.
Frequently Asked Questions
How do I access my CME/CE Credits?
A link will be provided you to you at the conclusion of the course. You will be asked to fill out a brief evaluation and your certificate will be automatically emailed back to you.
How long do I have access to the course?
This CME course will be available to access until April 9, 2023.
Can I have face to face interaction with Instructor?
No, this is an online self-paced course with video demonstration. However, you are free to connect with the medical experts for each session on social media or contact the team and we will connect you.
How many credits can I obtain?
Amedco LLC designates this enduring activity for a maximum of 4.50 AMA PRA Category 1 CreditsTM for physicians and 4.50 contact hours for nurses. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Cancer Care in the Time of COVID19 Learners Notification
Taking Care of Cancer Survivors Through Crisis
Challenges in Community Oncology
Breast Cancer and COVID19
Gastrointestinal Cancer and COVID19
Navigating Lung Cancer in Today’s New Normal
GYN Surgery and COVID19
Radiation Oncology and COVID19
A Patient’s Perspective on COVID19